Adverum Biotechnologies Inc (NASDAQ:ADVM)

1.20
Delayed Data
As of 3:59pm ET
 +0.01 / +0.84%
Today’s Change
0.53
Today|||52-Week Range
2.34
+107.08%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$151.5M

Company Description

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.

Contact Information

Adverum Biotechnologies, Inc.
100 Cardinal Way
Redwood City California 94063
P:(650) 656-9323
Investor Relations:

Employees

Shareholders

Other institutional42.19%
Individual stakeholders4.43%
Mutual fund holders14.19%

Top Executives

Laurent FischerPresident, Chief Executive Officer & Director
Peter SoparkarChief Operating & Legal Officer
Linda M. RubinsteinChief Financial & Accounting Officer
Heikki JouttijärviSenior VP & Head-Technical Operations
Bill TanSVP & Head-Global Clinical Operations